An interventional study of Tai Chi exercise and self management in Metabolic Syndrome, sponsored by Chungnam National University. Completed at 1 site in Korea, Republic of. Per ClinicalTrials.gov, last updated 2022-03-09.
Sponsored by Chungnam National University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 53 studies in Metabolic Syndrome with a site in Korea, Republic of — 4 open to participants now, 4 under way, none of them phase 3. Metabolic Syndrome · Korea, Republic of.
Among the 53 studies in Metabolic Syndrome with a site in Korea, Republic of, this one is the 17th largest by enrollment of the 31 interventional ones that give a count, is one of 2 that started in 2020, is one of 17 with no phase, and was the 47th registered.
2,119 studies on the registry are indexed under Metabolic Syndrome; 350 are open to participants now.
Browse Metabolic Syndrome studies →4 of the 53 studies in Metabolic Syndrome with a site in Korea, Republic of are open now. Recruiting first, the newest first:
JW Pharmaceutical · Sites in Korea, Republic of
Ages 19+
Korea University Anam Hospital · Sites in Korea, Republic of
Ages 19+
Samsung Medical Center · Sites in Korea, Republic of
Ages 40+
Hallym University · Sites in Korea, Republic of
Ages 20–70
A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →
Of the 234 Metabolic Syndrome studies recruiting now, 70 (30%) set no upper age limit and 135 (58%) stop at 75 or younger; 20 take children under 18; 81 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
53 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 2 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 65 is close to the median of 60 across 1,574 interventional studies indexed under Metabolic Syndrome.
Median enrollment 67 across the 31 interventional studies, 150 across the 22 observational. Of the 31 that completed or were terminated, 2 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
10 of 53 have an industry lead sponsor. The 10 most frequent:
Chungnam National University is the lead sponsor of 12 studies on the registry; 2 are open to participants now.
Chungnam National University has 1 study filed under Metabolic Syndrome — fewer than ten, so there is no comparison to draw.
1 of the studies in Metabolic Syndrome with a site in Korea, Republic of that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07523971JW PharmaceuticalEfficacy and Safety of Pitavastatin/Ezetimibe in Dyslipidemia Patients With Metabolic Syndrome: An Observational Study | 2026-12 |
Add it to your calendar (.ics) → With an account.
Among the 53 studies in Metabolic Syndrome with a site in Korea, Republic of, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This is the randomized trial to explore the effect of behavioral modification program (Tai Chi vs. self management) on adults with metabolic syndrome. The outcome variables include health behavior, metabolic syndrome indicators, quality of life.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Tai Chi exercise intervention provided twice a week for one hour for 12 weeks
Behavioral: Tai Chi exercise
self management program provided 6 sessions (one hour per session) for 12 weeks
Behavioral: self management
Yang style Tai Chi 16 movements
health education and dietary counseling
Change in Cardiac health behavior scale
cardiac health behaviors scale including exercise, diet, stress management, health responsibility, and smoking - 25 items in 4 point Likert scale
Time frame: change from baseline health behavior score at 3 months
Change in blood pressure
systolic and diastolic blood pressure (mmHg)
Time frame: change from baseline blood pressure at 3 months
change in lipid profile
high density lipoprotein(HDL), low density lipoprotein(LDL), total cholesterol, triglyceride
Time frame: change from baseline lipid profile at 3 months
Change in blood glucose
HbA1C
Time frame: change from baseline blood glucose at 3 months
Change in abdominal obesity
waist circumference (in centimeters) will be measured with indicator on upper hip bone
Time frame: change from baseline waist circumference at 3 months
Change in quality of life
health related quality of life (by SF36 v.2) to calculate mental and physical components in 100 points
Time frame: change from baseline QOL score at 3 months
Ran from Dec 2020 to primary completion in Jan 2022, 13 months.
Of 627 non-industry interventional studies with no phase under Metabolic Syndrome, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 41. This study's 13 months is below that.
Counting every sponsor, half of 677 studies reached it within 20 months; a quarter within 9 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chungnam National University